Increased production of hydrogen peroxide by peripheral blood monocytes associated with smoking exposure intensity in smokers
© Tanni et al.; licensee BioMed Central Ltd. 2012
Received: 18 May 2012
Accepted: 13 November 2012
Published: 21 November 2012
Smoking is known to be associated with oxidative stress; however, it has not been elucidated whether the oxidative response is influenced by the intensity of smoking exposure.
Evaluate the effect of smoking exposure on the secretion of hydrogen peroxide (H2O2) by the peripheral blood monocytes of smokers.
A total of 25 smokers (50.3±8.8 years, 48% male) underwent the following evaluations: spirometry, pulse oximetry, body composition and total peripheral blood count. Peripheral blood monocyte (PBM) cultures were isolated and maintained, and IL-6 and TNF-α were measured in the plasma and in the supernatants of spontaneous and stimulated cultures. H2O2 was evaluated in the supernatants of the PBM cultures, and a subset of the PBM culture supernatants was stimulated with phorbol myristate acetate (PMA). We also evaluated 38 healthy controls (49.1±8.2 years, 42% male).
The spontaneous and stimulated monocytes’ secretion of H2O2 were statistically higher in the smokers than in the healthy controls (p<0.001). The H2O2 secretions were statistically significant higher after stimulation with PMA in both groups (p<0.001). In the multiple regression analysis, we identified a positive, statistically significant association between pack-years of smoking and the spontaneous secretion of H2O2 by PBM culture, adjusted for potential confounding variables. The association between PBM culture secretion of H2O2 and the production of TNF-α and IL-6 was not significant.
We identified a positive association between higher production of H2O2 in smokers and higher smoking exposure during life. The influence of pack-years smoking may be a key modifiable factor in oxidative stress associated to smoking.
KeywordsHydrogen peroxide Smoking Oxidative stress Systemic inflammation Cultured cells
Smoking is a major agent of environmental pollution and is the leading preventable cause of death worldwide. According to data from the World Health Organization, smoking is responsible for 85% of deaths due to chronic obstructive pulmonary disease (COPD), 30% of cancer deaths and 25% of deaths from coronary disease. The development of smoking-related diseases is associated with the deleterious effects of cigarette smoke, including increased oxidative stress and inflammatory processes[2, 3].
Oxidative stress is associated with higher concentrations of reactive oxygen specimens, including hydrogen peroxide (H2O2), and this phenomenon is a characteristic response of inflammatory cells to smoking[4–7]. Oxidative stress can further stimulate the inflammatory process in the airways, increasing the levels of cytokines and the accumulation of polymorphonuclear leukocytes (PMNs)[2, 8–10]. Moreover, this stress may induce the oxidation of lipids, lipoproteins, DNA and other proteins and molecules in ways that impair normal cellular function and enable the development of many diseases, such as COPD and atherosclerosis. COPD patients present higher concentrations of H2O2 in exhaled breath condensate compared with healthy controls, which might be associated with smoking exposure. Oxidative stress activates proteins that are associated with the destruction of parenchymal tissue.
An association between active smoking and elevated oxidative stress in alveolar macrophages is well described in the literature[2, 12, 13]; however, whether the intensity of smoking exposure has an impact on oxidative stress has been less thoroughly investigated. In the study of van Beurden et al., the production of superoxide by PMNs was not associated with the intensity of smoking exposure evaluated by smoking history duration. Similarly, Yeh et al. did not find an association with smoking history duration when protein carbonylation was used as a biomarker for oxidative stress. Therefore, the aim of this study was to assess the relationship between systemic oxidative stress, represented by the secretion of H2O2 by peripheral monocytes, and pack-years of smoking.
We evaluated 25 active smokers (52% female) of at least 10 pack-years and 38 healthy controls self-identified as never smokers (57.9% female). All of the participants underwent routine clinical assessments, including spirometry and chest X-ray. The height and weight were measured, and the body mass index (BMI) was calculated (kg/m2). The exclusion criteria included pharmacological treatments in the last three months before enrollment in the study, a forced expiratory volume in the first second (FEV1)/Forced vital capacity (FVC) ratio < 0.70 or significant reversibility (increase >200 mL or >11% in the value of FEV1 expressed as percentage of the predicted value) 20 minutes after the inhalation of a β2-agonist (400 mcg fenoterol) in the spirometry test, diagnosis of any chronic disease, and inability to understand the study protocol.
The Research Ethics Committee of the Botucatu Medical School approved the study design, and all of the participants gave written informed consent.
Spirometry test and pulse oximetry
The FEV1 and FVC were obtained from the flow-volume curve using a spirometer (Ferraris KOKO, Louisville, CO, USA) before and 20 minutes after the inhalation of a β2-agonist (400 mcg fenoterol) according to Brazilian guidelines. The highest value of at least three measurements was selected and expressed as a percentage of reference values. The pulse oximetry (SpO2%) was assessed by a portable oximeter (Nonin Medical, Plymouth, MN, USA).
Peripheral blood monocyte isolation and culture (PBM)
PBM cultures were isolated from heparinized blood drawn between 07:00 – 08:00 using a density gradient followed by plastic adherence, as described elsewhere. In brief, the PBM cultures were isolated from heparinized blood using Histopaque 1077 (Sigma Chemical Co., St Louis, MO, USA) and washed three times with Hanks’ solution (Sigma Chemical Co.). A cell suspension was prepared with PBMCs at 2×106 cells·mL-1 in Roswell Park Memorial Institute (RPMI)-1640 medium (Sigma Chemical Co.) supplemented with 5% heat-inactivated autologous serum, 2 mM glutamine, 100 U·mL-1 penicillin and 10 mM HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid) buffer (that hereafter will be referred to as mRPMI) and incubated for 2 hours in a humidified atmosphere with 5% CO2 at 37°C. Nonadherent cells were removed by three washes with plain RPMI and counted. The adherent cells were provided with fresh mRPMI at a volume of 1 mL·1×106 cells-1 and incubated for 24 hours. The supernatants were collected, centrifuged and stored at −80°C until cytokine analysis. After the supernatants were harvested, the adherent cells were stained with nonspecific esterase staining (Sigma Chemical Co.), and the cell viability was determined using a trypan blue exclusion test. The adherent cells contained > 95% monocytes; >98% were viable.
Interleukin (IL)-6 and tumor necrosis factor alpha (TNF-Î±) measurements
Fasting peripheral blood was collected in the early morning (07.00-08.00 hours), and the plasma was stored at −80°C until analysis. TNF-α and IL-6 in the spontaneous PBM culture supernatant and plasma were assessed in duplicate by highly sensitive commercial kits using the enzyme-linked immunosorbent (ELISA) technique according to the manufacturer’s instructions (BioSource International Inc, CA, USA). The lower detection limits were 0.5 pg/mL for TNF-α and 0.16 pg/mL for IL-6.
The production of H2O2 was determined according to the method described by Pick & Keisari, adapted by Pick & Mizel and also previous published. After an 18-hour incubation period, supernatants of cultures of monocytes were discarded, and the cells were resuspended to the original volume in phenol red solution containing 140 mM of NaCl; 10 mM of phosphate-buffered saline (pH 7); 5.5 mM of dextrose; 0.56 mM phenol red; and 0.01 mg/ml of horseradish peroxidase, type II (Sigma Chemical Co, USA). The supernatants were divided into two parts, incubated with or without 1 μg of phorbol myristate acetate (PMA) and used as positive controls for H2O2. After 1 hour, the reaction was interrupted by the addition of 0.01 ml of 1 N NaOH. The samples were assayed in quadruplicate. The absorbance was determined using an ELISA reader at 620 nm against a blank containing phenol red and 1 N NaOH.
The results were expressed as nanomoles of H2O2/2×105 cells using the standard curve established in each assay and made up of known molar concentrations of H2O2 in phenol red buffer solution. In these experimental conditions, the curve was generated based on the following concentrations: 0.5; 1.0; 1.5 and 2.0 nM of H2O2.
The results are presented as the means ± SD for normally distributed variables and the median (range) when not normally distributed. The independent t test or Mann–Whitney was used to compare groups according to smoking status. The Chi-square test was used to compare proportions between groups. To explore the association of H2O2 with markers of systemic inflammation (TNF-α, IL-6 and neutrophils) and with pack-years of smoking, we performed multiple regression analysis with robust standard errors with and without adjustment for potential confounding variables. A p value of less than 0.05 denotes statistically significant difference (“STATA” 10.0 - Corp, College Station, TX, USA).
Peripheral blood cells, serum values and spontaneous monocyte secretion of TNF-α and IL-6
TNF-α serum (pg/ml)
IL-6 serum (pg/ml)
IL-6 monocytes (pg/ml) *
Multiple regression models for spontaneous and stimulated monocyte production of H 2 O 2
95% confidence interval
95% confidence interval
Spontaneous production H 2 O 2
Stimulated production H 2 O 2
TNF-α serum (pg/ml)
TNF-α monocytes (pg/ml)
IL-6 serum (pg/ml)
IL-6 monocytes (pg/ml)
We did not find associations between H2O2 secretion with systemic inflammation evaluated by serum values and PBM culture secretion of TNF-α or IL-6 or the number of neutrophils in the peripheral blood (Table 3).
This study aimed to evaluate the relationship between systemic oxidative stress and intensity of smoking exposure. The main finding was that the smokers exhibited significantly higher secretion of H2O2 than the healthy controls and that there was a significantly positive association of oxidative stress with pack-years of smoking. These results confirm that smoking itself is an important determinant of oxidative stress and that a higher consumption of cigarettes is associated with higher levels of oxidative stress[12, 14, 20]. We also reinforce previous findings that smokers exhibit evidence of systemic inflammation compared with healthy controls[7, 21].
The relationship between intensity of smoking exposure, through the evaluation of smoking pack-years, and oxidative stress has previously been investigated in the literature. However, our study is the first to show a significant association between pack-years of smoking and the secretion of H2O2 by PBMs. Thomassen et al. did not find a correlation between the number of pack-years of smoking and the secretion of H2O2 by alveolar macrophages when assessing smokers and non-smokers. Similarly, Puri et al. found no correlation between exhaled ethane air levels and cumulative smoking status. It is difficult to compare our results with those of these studies. The study by Thomassen et al. used different cultures of cells to evaluate the secretion of H2O2. Those authors assessed alveolar macrophages, whereas we evaluated PBM cultures. Similarly, Puri et al. used a different outcome to quantify oxidative stress. However, the sample size of these studies was smaller than that in our study.
In this study, we demonstrated the higher secretion of H2O2 in smokers by PBM cultures, either spontaneously or after stimulation. Nowak et al. demonstrated increased content of H2O2 in the expired breath condensate of cigarette smokers compared with controls. Our results are also in agreement with those of Ishida et al., who identified higher H2O2 production in alveolar macrophage cultures of rats exposed to cigarette smoke. In contrast to our results, van Beurden et al. did not detect differences in the release of superoxide dismutase by PBM cultures, either spontaneously or after stimulation with PMA, between COPD current/ex-smoker patients and healthy controls, and the smoking history did not influence the results when compared by covariance analysis between groups. The authors concluded that superoxide dismutase is only one of the oxidants that are produced by PBM culture; these cells also produce H2O2 and hydroxyl radicals. Therefore, the fact that the secretion of H2O2 by PBM culture is higher in smokers may indicate an imbalance in which the production of reactive oxygen species exceeds the capacity of the antioxidant defense systems in the systemic microenvironment. The oxidative stress may already be occurring to produce oxygen free radicals.
Our results showed higher secretion in H2O2 after stimulation with PMA in both groups, and the smokers exhibited higher production than the controls. This result indicates that the smokers included in our study still have monocytes with efficient immune capacity. We can speculate that monocyte phagocytosis in smokers is still functional, although we did not evaluate the immune capacity in our study. In contrast, Correa et al. showed lower fungicidal activity and secretion of H2O2 by the monocytes of patients with peripheral atherosclerosis obliterans compared with those of control subjects.
Cigarette smoke induces the enhanced recruitment of mononuclear phagocytes and polymorphonuclear cells into the lower airways[2, 12], and these cells modify oxygen metabolism and release additional H2O2 and other reactive oxygen species. In our results, we identified a statistically higher number of neutrophil cells in the peripheral blood of smokers in comparison with that of healthy controls and a positive association between the numbers of leukocytes cells and pack-years of smoking. These observations are in accordance with a previous study that demonstrated an accelerated release of polymorphonuclear leukocytes from the bone marrow after smoking exposure.
The systemic inflammation induced by smoking includes neutrophilia and cytokines[6, 27, 28]. In our study, we found higher levels of TNF-α in smokers compared with healthy controls. Similarly, Tanni et al. and Pretescu et al. showed higher TNF-α levels in smokers compared with healthy non-smokers. We did not find differences in the cytokine secretion by the PBM culture in both groups, and the literature reveals controversial results that are dependent on the cell culture methods[7, 21]. In agreement with our results, Ryder et al. utilized cell cultures without stimulus and did not find increased values of TNF-α production by PBM cultures in smokers compared with controls. In contrast, Zeidel et al. identified increased production of the pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) in smokers compared with non-smoking subjects, however, these authors analyzed cell cultures stimulated with lipopolysaccharide.
The limitations of our study need to be addressed. First, this study is cross sectional, and we are not explaining the cause-and-effect relationships among events. Second, we did not evaluate whether different smoking pack-years or cigarettes-day can induce greater secretion of H2O2 to confirm our results. Third, we did not assess the other biomarkers of oxidative stress and antioxidants to better understand the biological response to smoking pack-years.
In conclusion, we identified an association between higher secretions of H2O2 and smokers compared with healthy controls. The influence of pack-years smoking may be a key modifiable factor in oxidative stress associated to smoking.
Research Grant from FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo, São Paulo, Brazil) N º 03/05285-1.
Body mass index
Chronic obstructive pulmonary disease
Forced expiratory volume in the first second
Forced vital capacity
Peripheral blood monocyte
Phorbol myristate acetate
Roswell park memorial institute
Tumor necrosis factor alpha.
- WHO. World Health Organization: Chronic respiratory diseases.http:www.hoint/en,
- Nowak D, Antczak A, Krol M, Pietras T, Shariati B, Bialasiewicz P: Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur Respir J. 1996, 9: 652-657. 10.1183/09031936.96.09040652.View ArticlePubMed
- Corrêa CR, Dias-Melicio LA, Calvi SA, Lastória S, Soares AM: Activation of monocytes and cytokine production in patients with peripheral atherosclerosis obliterans. J Inflamm. 2011, 29: 23-View Article
- Lerner L, Weiner D, Katz R, Reznick AZ, Pollack S: Increased pro-inflammatory activity and impairment of human monocyte differentiation induced by in vitro exposure to cigarette smoke. J Physiol Pharmacol. 2009, 60 (Suppl 5): 81-86.PubMed
- Wirtz PH, von Känel R, Kunz-Ebrecht S, Ehlert U, Fischer JE: Enhanced glucocorticoid sensitivity of cytokine release from circulating leukocytes stimulated with lipopolysaccharide in healthy male smokers. Brain Behav Immun. 2004, 18: 536-543. 10.1016/j.bbi.2004.01.002.View ArticlePubMed
- van Eeden SF, Hogg JC: The response of human bone marrow to chronic cigarette smoking. Eur Respir J. 2000, 15: 915-921. 10.1034/j.1399-3003.2000.15e18.x.View ArticlePubMed
- Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, Bessler H: Immune response in asymptomatic smokers. Acta Anaesthesiol Scand. 2002, 46: 959-964. 10.1034/j.1399-6576.2002.460806.x.View ArticlePubMed
- Barbieri SS, Amadio P, Gianellini S, Zacchi E, Weksler BB, Tremoli E: Tobacco smoke regulates the expression and activity of microsomal prostaglandin E synthase-1: role of prostacyclin and NADPH-oxidase. FASEB J. 2011, 25: 3731-3740. 10.1096/fj.11-181776.View ArticlePubMed
- Petrescu F, Voican SC, Silosi I: Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. Int J Chron Obstruct Pulmon Dis. 2010, 5: 217-222.PubMed CentralPubMed
- Lima DF, Coleta KD, Tanni SE, Godoy I, Silveira LVA, Godoy I: Potentially modifiable predictors of mortality in patients treated with long-term oxigen therapy. Respir Med. 2010, 105: 470-476.View ArticlePubMed
- Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL: Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996, 154: 813-816.View ArticlePubMed
- Guatura SB, Martinez JA, Santos Bueno PC, Santos ML: Increased exhalation of hydrogen peroxide in healthy subjects following cigarette consumption. Sao Paulo Med J. 2000, 118: 93-98. 10.1590/S1516-31802000000400004.View ArticlePubMed
- Bloomer RJ, Solis AD, Fisher-Wellman KH, Smith WA: Postprandial oxidative stress is exacerbated in cigarette smokers. Br J Nutr. 2008, 99: 1055-1060.View ArticlePubMed
- van Beurden WJ, Wielders PL, Scheepers PJ, van Herwaarden CL, Dekhuijzen PN: Superoxide production by peripheral polymorphonuclear leukocytes in patients with COPD. Respir Med. 2003, 97: 401-406. 10.1053/rmed.2002.1461.View ArticlePubMed
- Yeh CC, Graham Barr R, Powell CA, Mesia-Vela S, Wang Y, Hamade NK: No effect of cigarette smoking dose on oxidized plasma proteins. Environ Res. 2008, 6: 219-225.View Article
- Pereira CAC, Neder JA: Diretrizes para testes de função pulmonar. J Bras Pneumol. 2002, 28: S2-S238.
- deGodoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM: Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med. 1996, 153: 633-637.View Article
- Pick E, Keisari Y: A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods. 1980, 8: 161-170.View Article
- Pick E, Mizel D: Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods. 1981, 46: 211-226. 10.1016/0022-1759(81)90138-1.View ArticlePubMed
- Ludwig PW, Hoidal JR: Alterations in leukocyte oxidative metabolism in cigarette smokers. Am Rev Respir Dis. 1982, 126: 977-980.PubMed
- Ryder MI, Saghizadeh M, Ding Y, Nguyen N, Soskolne A: Effects of tobacco smoke on the secretion of interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta from peripheral blood mononuclear cells. Oral Microbiol Immunol. 2002, 17: 331-336. 10.1034/j.1399-302X.2002.170601.x.View ArticlePubMed
- Thomassen MJ, Barna BP, Wiedemann HP, Farmer M, Ahmad M: Human alveolar macrophage function: differences between smokers and nonsmokers. J Leukoc Biol. 1988, 44: 313-318.PubMed
- Puri BK, Treasaden IH, Cocchi M, Tsaluchidu S, Tonello L, Ross BM: A comparison of oxidative stress in smokers and non-smokers: an in vivo human quantitative study of n-3 lipid peroxidation. BMC Psychiatry. 2008, 8 (Suppl 1): S4-10.1186/1471-244X-8-S1-S4.PubMed CentralView ArticlePubMed
- Ishida T, Pinkerton KE, Takeuchi M: Alveolar macrophage from cigarette smoke-exposed mice inhibits B lymphocyte proliferation stimulated with LPS. Respiration. 2008, 77: 91-95.View ArticlePubMed
- Opara EC: Oxidative stress. Dis Mon. 2006, 52: 83-98.
- DeChatelet LR, Shirley PS, Johnston RBJ: Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood. 1976, 47: 545-554.PubMed
- Tappia PS, Troughton KL, Langleyevans SC, Grimble RF: Cigarette-smoking influences cytokine production and antioxidant defenses. Clin Sci. 1995, 88: 485-489.View ArticlePubMed
- Tanni SE, Pelegrino NR, Angeleli AY, Correa C, Godoy I: Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm. 2010, 7: 29-10.1186/1476-9255-7-29.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.